You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 7月20日港股收盤

根據uSMART輿情監測數據,20日港股交易時段,市場關注指數最高的5只股票是藥明生物、商湯-W、嗶哩嗶哩-SW、耐世特、信達生物。

7月20日—港股關注排行TOP5

輿情變化榜單

藥明生物

個股K線圖

關注度第一爲藥明生物,該股今日收盤上漲2.58%,報於79.55港元。近5個交易日累計上漲5.02%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

中金:維持藥明生物“跑贏行業“評級 目標價上調至96.8港元

CRDMO公司藥明生物計劃在新加坡投資建設一體化CRDMO服務中心

商湯-W

個股K線圖

關注度第二爲商湯-W,該股今日收盤上漲10.95%,報於2.33港元。近5個交易日累計下跌2.51%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

商湯反彈7% 昨日回購670萬股 爲上市以來首次

港股商湯盤中漲超13% 此前公告稱公司上市後首次回購股份

嗶哩嗶哩-SW

個股K線圖

關注度第三爲嗶哩嗶哩-SW,該股今日收盤上漲6.44%,報於201.60港元。近5個交易日累計上漲3.92%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

強勢反彈!恆生科指漲逾2%,嗶哩嗶哩大漲超8%,港股業績潮即將來襲,答卷會表現如何?

港股科技股集體高開:嗶哩嗶哩漲超5%,阿裏漲超3%

耐世特

個股K線圖

關注度第四爲耐世特,該股今日收盤下跌8.63%,報於5.19港元。近5個交易日累計下跌5.12%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

花旗下調耐世特目標價至7.6港元 指其今年上半年業績承壓

花旗下調耐世特目標價至7.6元 評級「買入」

信達生物

個股K線圖

關注度第五爲信達生物,該股今日收盤上漲4.24%,報於36.90港元。近5個交易日累計上漲1.51%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

國金證券:維持信達生物“買入”評級 GLP-1產品Mazdutide達到主要臨牀終點

信達生物反彈3.39% mazdutide II期臨牀研究達到主要終點

此外,監測期內有2只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。

7月20日—港股輿情轉折預警

輿情變化榜單

百度集團-SW

個股K線圖

百度集團-SW輿情扭轉指數達100,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

百度集團漲超4% 高盛仍看好其廣告業務的復甦前景

高盛維持百度集團“買入”評級 看好其下半年廣告、雲業務復甦增長前景

嗶哩嗶哩-SW

個股K線圖

嗶哩嗶哩-SW輿情扭轉指數達99,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

強勢反彈!恆生科指漲逾2%,嗶哩嗶哩大漲超8%,港股業績潮即將來襲,答卷會表現如何?

港股科技股集體高開:嗶哩嗶哩漲超5%,阿裏漲超3%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account